Literature DB >> 15723564

Deletions in the DNA-binding domain of the TP53 gene in v-src-transformed chicken cells.

Katerina Trtková1, Jirí Plachý.   

Abstract

We have examined the chicken TP53 tumor suppressor gene in v-src-transformed chicken tumor cells by reverse transcriptase-polymerase chain reaction and deoxyribonucleic acid (DNA) sequencing. Initially, we have detected frequent deletions of variable length in both DNA-binding and oligomerization domains of the TP53 in late as well as early in vitro passages of the chicken tumor cell line PR9692. This tumor cell line shows an immortal phenotype and acquires a metastatic potential that is unique in our experimental model of v-src-induced tumors in congenic chickens. Deletions in TP53 were also detected in an early passage of parallel in vivo subculture of the original v-src-induced tumor. In this case, tumor cells underwent replicative senescence later in tissue culture. Our results suggest that extensive deletions are efficient mechanisms of TP53 inactivation, occurring as early events during the immortalization of v-src-transformed chicken cells. Tumor cells with altered TP53 might, however, still be susceptible to growth control mechanisms, leading to withdrawal from the mitotic cycle in the early stage of the tumor lifeline.

Entities:  

Mesh:

Year:  2004        PMID: 15723564     DOI: 10.1290/0312091.1

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  44 in total

Review 1.  Cancer: is there involved a bunch of culprits, one culprit, or something in between?

Authors:  J Svoboda
Journal:  Folia Biol (Praha)       Date:  2000       Impact factor: 0.906

2.  Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt.

Authors:  Y Hakak; Y S Hsu; G S Martin
Journal:  Oncogene       Date:  2000-06-29       Impact factor: 9.867

Review 3.  Senescence, apoptosis and therapy--cutting the lifelines of cancer.

Authors:  Clemens A Schmitt
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  Regulation of both apoptosis and cell survival by the v-Src oncoprotein.

Authors:  D Johnson; M Agochiya; K Samejima; W Earnshaw; M Frame; J Wyke
Journal:  Cell Death Differ       Date:  2000-08       Impact factor: 15.828

Review 6.  Src in cancer: deregulation and consequences for cell behaviour.

Authors:  Margaret C Frame
Journal:  Biochim Biophys Acta       Date:  2002-06-21

7.  Activating SRC mutation in a subset of advanced human colon cancers.

Authors:  R B Irby; W Mao; D Coppola; J Kang; J M Loubeau; W Trudeau; R Karl; D J Fujita; R Jove; T J Yeatman
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

Review 8.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

9.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

Review 10.  Chicken cells--oncogene transformation, immortalization and more.

Authors:  J Plachý; J Hejnar
Journal:  Folia Biol (Praha)       Date:  2002       Impact factor: 0.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.